InterCure Statistics

Total Valuation

InterCure has a market cap or net worth of ILS 266.71 million. The enterprise value is 400.16 million.

Market Cap	266.71M
Enterprise Value	400.16M

Important Dates

The next estimated earnings date is Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

InterCure has 47.16 million shares outstanding. The number of shares has increased by 0.65% in one year.

Current Share Class	47.16M
Shares Outstanding	47.16M
Shares Change (YoY)	+0.65%
Shares Change (QoQ)	-7.94%
Owned by Insiders (%)	38.42%
Owned by Institutions (%)	7.01%
Float	26.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.12
PB Ratio	0.67
P/TBV Ratio	1.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.90
EV / Sales	1.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.61

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.53.

Current Ratio	1.73
Quick Ratio	0.96
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	-2.96
Interest Coverage	-4.26

Financial Efficiency

Return on equity (ROE) is -17.03% and return on invested capital (ROIC) is -8.71%.

Return on Equity (ROE)	-17.03%
Return on Assets (ROA)	-7.09%
Return on Invested Capital (ROIC)	-8.71%
Return on Capital Employed (ROCE)	-16.40%
Revenue Per Employee	746,391
Profits Per Employee	-211,859
Employee Count	320
Asset Turnover	0.31
Inventory Turnover	1.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.81% in the last 52 weeks. The beta is 0.51, so InterCure's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-54.81%
50-Day Moving Average	546.52
200-Day Moving Average	600.49
Relative Strength Index (RSI)	51.33
Average Volume (20 Days)	36,956

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InterCure had revenue of ILS 238.85 million and -67.80 million in losses. Loss per share was -1.48.

Revenue	238.85M
Gross Profit	42.05M
Operating Income	-87.89M
Pretax Income	-87.32M
Net Income	-67.80M
EBITDA	-78.22M
EBIT	-87.89M
Loss Per Share	-1.48

Full Income Statement

Balance Sheet

The company has 78.65 million in cash and 211.40 million in debt, giving a net cash position of -132.75 million or -2.81 per share.

Cash & Cash Equivalents	78.65M
Total Debt	211.40M
Net Cash	-132.75M
Net Cash Per Share	-2.81
Equity (Book Value)	397.67M
Book Value Per Share	8.42
Working Capital	165.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -66.93 million and capital expenditures -4.38 million, giving a free cash flow of -71.30 million.

Operating Cash Flow	-66.93M
Capital Expenditures	-4.38M
Free Cash Flow	-71.30M
FCF Per Share	-1.51

Full Cash Flow Statement

Margins

Gross margin is 17.61%, with operating and profit margins of -36.80% and -28.38%.

Gross Margin	17.61%
Operating Margin	-36.80%
Pretax Margin	-36.56%
Profit Margin	-28.38%
EBITDA Margin	-32.75%
EBIT Margin	-36.80%
FCF Margin	n/a

Dividends & Yields

InterCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.65%
Shareholder Yield	-0.65%
Earnings Yield	-25.42%
FCF Yield	-26.73%

Stock Splits

The last stock split was on April 8, 2021. It was a reverse split with a ratio of 0.2247564764.

Last Split Date	Apr 8, 2021
Split Type	Reverse
Split Ratio	0.2247564764

Scores

InterCure has an Altman Z-Score of 0.24. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.24
Piotroski F-Score	n/a